US 10137193
Methods for treating or preventing asthma by administering an IL-4R antagonist
granted A61KA61K2039/54A61K2039/545
Quick answer
US patent 10137193 (Methods for treating or preventing asthma by administering an IL-4R antagonist) held by REGENERON PHARMACEUTICALS, INC. expires Mon Nov 22 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Nov 27 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 22 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 30
- CPC classes
- A61K, A61K2039/54, A61K2039/545, A61K31/00, A61K31/137